The removal of 5 pharmaceuticals from the market in a
12-month period because of unexpected adverse events raised concerns
about the adequacy of the drug review process at the US Food and Drug
Administration (FDA). Specifically, concerns were raised about
improvements in drug review efficiency that significantly reduced FDA
review times. We have reviewed the circumstances of the 5 removals to
determine whether there was any relationship to the increased
efficiencies in the drug review process. When the removed drugs were
analyzed by date of approval, no increase in the number of drugs taken
off the market was seen, demonstrating that reduced review processing
time was not the reason for the cluster of removals. We conclude that
the agency's drug review procedures and postmarketing surveillance
system after a drug has been marketed are currently adequate but must
continually adjust to future challenges.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 127
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.